Trial Profile
An open-label, 2-part study to evaluate the effect of ethnic variability on tildrakizumab in Caucasian, Chinese, and Japanese subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Tildrakizumab (Primary) ; Tildrakizumab (Primary)
- Indications Psoriasis
- Focus Pharmacokinetics
- 18 Nov 2015 New trial record